Skip to main content
. 2016 Dec 29;11:115–125. doi: 10.2147/OPTH.S121307

Table S2.

Predictors of bad outcome (BCVA >1 logMAR)

Variables Univariate
Multivariate
OR 95% CI Significance OR 95% CI Significance
Right eye 0.587 0.241–1.432 P=0.241 NI
Hypercholesterolemia 0.628 0.270–1.457 P=0.278 NI
Hypertension 0.773 0.317–1.882 P=0.570 NI
Number of HBOT sessions 0.819 0.577–1.1162 P=0.263 NI
Previous aspirin 0.836 0.360–1.940 P=0.676 NI
Sex 0.948 0.386–2.331 P=0.908 NI
Diabetes mellitus 0.975 0.350–2.711 P=0.961 NI
IOP 0.989 0.902–1.084 P=0.812 NI
Age 1.015 0.984–1.048 P=0.677 NI
Previous statin 1.04 0.424–2.547 P=0.932 NI
Time delay symptoms to Tx 1.125 0.985–1.285 P=0.083 NI
Plaque in fundus 1.143 0.349–3.741 P=0.825 NI
Massage 1.225 0.470–3.195 P=0.678 NI
Other vasculopathy 1.317 0.407–4.265 P=0.646 NI
Stroke 1.444 0.298–7.010 P=0.648 NI
Active smoking 1.687 0.654–4.354 P=0.279 NI
Ischemic heart disease 1.725 0.638–4.670 P=0.283 NI
Boxcarring in fundus 1.792 0.564–5.697 P=0.323 NI
Paracentesis 2.602 1.049–6.457 P=0.039 NI
Aspirin 2.67 0.324–22.029 P=0.362 NI
Acetazolamide PO 2.778 0.772–9.993 P=0.118 NI
Acetazolamide E 2.854 0.620–13.126 P=0.178 NI
Previous anti-coagulation 3.000 0.367–24.502 P=0.305 NI
Baseline logMAR 6.115 2.488–15.029 P<0.0001 3.993 1.277–12.490 P=0.017
Cherry-red spot 25.579 7.935–82.455 P<0.0001 16.488 4.857–55.979 P<0.0001

Notes: Baseline BCVA and presence of CRS at presentation were the only significant variables after multivariate analysis. The fundus finding of CRS at presentation was the strongest predictor with OR of 16.488 for a bad outcome. Bold text marks statistical significance (P<0.05).

Abbreviations: BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; OR, odds ratio; CI, confidence interval; NI, not included in multivariate analysis due to non-significance; HBOT, hyperbaric oxygen therapy; IOP, intraocular pressure; Tx, treatment; CRS, cherry-red spot; PO, per oral; E, eye drops.